BioStem Technologies stock forecast
Want to see BSEM full AI Analyst Report?
BioStem Technologies (BSEM) Stock Forecast & Price Target
BSEM Analyst Ratings
BSEM Stock 12 Month Forecast
Average Price Target
$7.00▲(566.67% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Swayampakula Ramakanth | H.C. Wainwright | $7 | buy | 566.67%Upside | Reiterated | 08/24/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Swayampakula RamakanthH.C. Wainwright | BuyReiterated$7 | 08/24/26 | 566.67%Upside |
Best Analysts Covering BioStem Technologies
Copying DeepSeek Biotechnology's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +12.27% per trade.
Copying DeepSeek Biotechnology's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +12.27% per trade.
Copying DeepSeek Biotechnology's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +12.27% per trade.
BSEM Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 1 | 1 | 1 | 0 |
In the current month, BSEM has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BSEM average Analyst price target in the past 3 months is 7.00.
BSEM Financial Forecast
BSEM Earnings Forecast
Next quarter’s earnings estimate for BSEM is -$0.45 with a range of -$0.45 to -$0.45. The previous quarter’s EPS was -$0.64. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
BSEM Sales Forecast
Next quarter’s sales forecast for BSEM is $7.53M with a range of $7.53M to $7.53M. The previous quarter’s sales results were $7.64M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

